← Leaderboards
Michael G Shlipak
Tufts Medical Center
$18,418,069
Attributed
$36,777,186
Total exposure
14
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,573,059 · 15
By mechanism
R01$31,051,811 · 10
U01$5,587,441 · 2
P30$795,873 · 1
R03$137,934 · 2
Top collaborators
- Joachim H Ix28 shared
- Mark J Sarnak18 shared
- Orlando M Gutierrez9 shared
- Michelle M Estrella7 shared
- Andrew S Levey5 shared
- Chirag R Parikh5 shared
- Samir M Parikh5 shared
- Steven G Coca3 shared
Most similar at Tufts Medical Center
Same institution · by research overlap
- Joachim H Ix$16,690,262
- Mark J Sarnak$10,155,302
- Orlando M Gutierrez$29,690,151
Others in their field
Top investigators on “Renal Function”
- David Heimbrook · Leidos Biomedical Research, Inc.$60,305,432
- Peter Scott Heeger · Case Western Reserve University$57,302,367
- David M Nathan · Massachusetts Institute Of Technology$55,535,097
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- John M Lachin · George Washington University$52,927,552
- Charles R Rinaldo · University Of Pittsburgh At Pittsburgh$38,834,764
Research focus
Renal FunctionKidneyKidney DiseasesChronic Kidney FailurePersonsSerumRisk FactorsUrineInjuryGlomerular Filtration RateBiological MarkersParticipantCreatinineCohortFollow-UpHigh RiskFibrosisCardiovascular DiseasesTubular FormationBaseFutureFunctional DisorderAdultDisease Progression
Grant awards (72)
Biomarker-Based Diagnostic Algorithms To Prevent, Detect And Guide Treatment Of Kidney Disease In Persons Living With HIV$1,437,384
R01 · FY2025 · AG · contact PI
Environmental Metal Toxicity and Kidney Tubule Measures in Diverse Populations$680,372
R01 · FY2025 · DK · contact PI
Non-SteroidAl Impact on Kidney Disease Study (NSAIDS)$660,616
R01 · FY2025 · DK
Dimensions of Kidney Tubule Health and Atherosclerotic Cardiovascular Disease and Heart Failure in Middle-Aged and Older Adults$625,475
R01 · FY2025 · HL
Environmental Metal Toxicity and Kidney Tubule Measures in Diverse Populations$738,587
R01 · FY2024 · DK · contact PI
Dimensions of Kidney Tubule Health and Atherosclerotic Cardiovascular Disease and Heart Failure in Middle-Aged and Older Adults$680,241
R01 · FY2024 · HL
Non-SteroidAl Impact on Kidney Disease Study (NSAIDS)$644,390
R01 · FY2024 · DK
Dimensions of Kidney Tubule Health and Atherosclerotic Cardiovascular Disease and Heart Failure in Middle-Aged and Older Adults$773,777
R01 · FY2023 · HL
Biomarker-Based Diagnostic Algorithms To Prevent, Detect And Guide Treatment Of Kidney Disease In Persons Living With HIV$746,193
R01 · FY2023 · AG · contact PI
Non-SteroidAl Impact on Kidney Disease Study (NSAIDS)$704,112
R01 · FY2023 · DK
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney Disease$591,938
R01 · FY2023 · DK
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOP-CKD)$523,979
U01 · FY2023 · DK
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOP-CKD)$349,999
U01 · FY2023 · DK
Biomarker-Based Diagnostic Algorithms To Prevent, Detect And Guide Treatment Of Kidney Disease In Persons Living With HIV$763,684
R01 · FY2022 · AG · contact PI
Role of Mitochondrial Health in Acute and Chronic Kidney Disease in Older Adults$677,939
R01 · FY2022 · AG · contact PI
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOP-CKD)$577,221
U01 · FY2022 · DK
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney Disease$576,792
R01 · FY2022 · DK
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOPÃÂÃÂÃÂâÃÂÃÂÃÂÃÂÃÂÃÂÃÂÃÂCKD)$200,000
U01 · FY2022 · DK
Biomarker-Based Diagnostic Algorithms To Prevent, Detect And Guide Treatment Of Kidney Disease In Persons Living With HIV$799,447
R01 · FY2021 · AG · contact PI
Role of Mitochondrial Health in Acute and Chronic Kidney Disease in Older Adults$685,746
R01 · FY2021 · AG · contact PI
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney Disease$650,208
R01 · FY2021 · DK
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOPÃÂÃÂÃÂâÃÂÃÂÃÂÃÂÃÂÃÂÃÂÃÂCKD)$599,552
U01 · FY2021 · DK
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOPÃÂÃÂÃÂâÃÂÃÂÃÂÃÂÃÂÃÂÃÂÃÂCKD)$150,000
U01 · FY2021 · DK
Kidney Tubular Injury and Dysfunction and Racial Disparities in Incident Hypertension and Kidney Function Decline$795,873
P30 · FY2020 · DK
Role of Mitochondrial Health in Acute and Chronic Kidney Disease in Older Adults$699,110
R01 · FY2020 · AG · contact PI
Impact of Exercise on Kidney Function and Injury among Elders in the LIFE Trial$691,041
R01 · FY2020 · DK · contact PI
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney Disease$664,281
R01 · FY2020 · DK
Beyond the Glomerulus: Novel Clinical Markers of Kidney Health and Prognosis$472,837
U01 · FY2020 · DK
Impact of Exercise on Kidney Function and Injury among Elders in the LIFE Trial$711,643
R01 · FY2019 · DK · contact PI
Role of Mitochondrial Health in Acute and Chronic Kidney Disease in Older Adults$711,421
R01 · FY2019 · AG · contact PI
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOPÃÂÃÂÃÂâÃÂÃÂÃÂÃÂÃÂÃÂÃÂÃÂCKD)$652,305
U01 · FY2019 · DK
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney Disease$644,112
R01 · FY2019 · DK
Kidney Health Biomarker Panels for Drug Toxicity and Prognosis in HIV Infection$610,991
R01 · FY2019 · AG · contact PI
Beyond the Glomerulus: Novel Clinical Markers of Kidney Health and Prognosis$249,984
U01 · FY2019 · DK
Role of Mitochondrial Health in Acute and Chronic Kidney Disease in Older Adults$792,748
R01 · FY2018 · AG · contact PI
Impact of Exercise on Kidney Function and Injury among Elders in the LIFE Trial$778,243
R01 · FY2018 · DK · contact PI
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOPâCKD)$666,605
U01 · FY2018 · DK
Kidney Health Biomarker Panels for Drug Toxicity and Prognosis in HIV Infection$617,711
R01 · FY2018 · AG · contact PI
Beyond the Glomerulus: Novel Clinical Markers of Kidney Health and Prognosis$250,000
U01 · FY2018 · DK
Kidney Health Biomarker Panels for Drug Toxicity and Prognosis in HIV Infection$624,242
R01 · FY2017 · AG · contact PI
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney$570,855
R01 · FY2017 · DK
Beyond the Glomerulus: Novel Clinical Markers of Kidney Health and Prognosis$99,997
U01 · FY2017 · DK
Beyond the Glomerulus: Novel Clinical Markers of Kidney Health and Prognosis$794,962
U01 · FY2016 · DK
Kidney Health Biomarker Panels for Drug Toxicity and Prognosis in HIV Infection$628,604
R01 · FY2016 · AG · contact PI
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney$607,359
R01 · FY2016 · DK
Kidney Health Biomarker Panels for Drug Toxicity and Prognosis in HIV Infection$651,898
R01 · FY2015 · AG · contact PI
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney$608,653
R01 · FY2015 · DK
The Aging Kidney: Chronic Injury, Impaired Functions and Clinical Outcomes$355,274
R01 · FY2015 · AG
Effects of Age and Race on GFR Estimation in a Population-based Cohort$236,269
R01 · FY2015 · DK
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney$653,166
R01 · FY2014 · DK
The Aging Kidney: Chronic Injury, Impaired Functions and Clinical Outcomes$509,322
R01 · FY2014 · AG
The Aging Kidney in HIV-Infection: biomarkers for early detection of injury$451,139
R01 · FY2014 · AG · contact PI
Effects of Age and Race on GFR Estimation in a Population-based Cohort$239,788
R01 · FY2014 · DK
The Aging Kidney: Chronic Injury, Impaired Functions and Clinical Outcomes$497,517
R01 · FY2013 · AG
The Aging Kidney in HIV-Infection: biomarkers for early detection of injury$451,564
R01 · FY2013 · AG · contact PI
Effects of Age and Race on GFR Estimation in a Population-based Cohort$243,415
R01 · FY2013 · DK
The Aging Kidney in HIV-Infection: biomarkers for early detection of injury$552,666
R01 · FY2012 · AG · contact PI
The Aging Kidney: Chronic Injury, Impaired Functions and Clinical Outcomes$518,629
R01 · FY2012 · AG
Effects of Age and Race on GFR Estimation in a Population-based Cohort$251,028
R01 · FY2012 · DK
The Aging Kidney: Chronic Injury, Impaired Functions and Clinical Outcomes$674,603
R01 · FY2011 · AG
The Aging Kidney in HIV-Infection: biomarkers for early detection of injury$576,020
R01 · FY2011 · AG · contact PI
Effects of Age and Race on GFR Estimation in a Population-based Cohort$266,358
R01 · FY2011 · DK
The Aging Kidney in HIV-Infection: biomarkers for early detection of injury$640,984
R01 · FY2010 · AG · contact PI
Kidney Disease, Antiretroviral Therapy and Cardiovascular Events in HIV-Infection$63,434
R03 · FY2010 · AG · contact PI
Heart Failure Incidence and Progression in Renal Disease$127,712
R01 · FY2008 · DK · contact PI
Heart Failure Incidence and Progression in Renal Disease$126,524
R01 · FY2007 · DK · contact PI
Heart Failure Incidence and Progression in Renal Disease$126,506
R01 · FY2006 · DK · contact PI
Heart Failure Incidence and Progression in Renal Disease$125,776
R01 · FY2005 · DK
Heart Failure Incidence and Progression in Renal Disease$126,238
R01 · FY2004 · DK
Elucidating the Kidney's Role in Cardiovascular Risk$125,750
R01 · FY2004 · HL
Elucidating the Kidney's Role in Cardiovascular Risk$125,750
R01 · FY2003 · HL
CHRONIC RENAL INSUFFICIENCY AND CARDIOVASCULAR MORTALITY$74,500
R03 · FY2001 · HL